Scarica l'app Stockscreener
20.25
1.45%
0.29
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$19.96
Aprire:
$20.03
Volume 24 ore:
520.58K
Relative Volume:
0.61
Capitalizzazione di mercato:
$1.27B
Reddito:
$330.50M
Utile/perdita netta:
$145.42M
Rapporto P/E:
12.27
EPS:
1.65
Flusso di cassa netto:
$157.96M
1 W Prestazione:
+5.63%
1M Prestazione:
-7.11%
6M Prestazione:
+9.76%
1 anno Prestazione:
+18.08%
Intervallo 1D:
$20.03
$20.40
Intervallo di 1 settimana:
$18.75
$20.40
Portata 52W:
$16.67
$22.00
Innoviva Inc Stock (INVA) Company Profile
Nome
Innoviva Inc
Settore
Industria
Telefono
(650) 238-9600
Indirizzo
1350 OLD BAYSHORE HIGHWAY, BURLINGAME
Confronta INVA con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INVA
Innoviva Inc
|
20.24 | 1.20B | 330.50M | 145.42M | 157.96M | 1.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.26 | 119.76B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
550.39 | 59.14B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.34 | 41.40B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
567.82 | 32.96B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
277.72 | 26.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Innoviva Inc Stock (INVA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-14 | Iniziato | H.C. Wainwright | Buy |
| 2025-07-11 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-03-07 | Iniziato | Scotiabank | Sector Outperform |
| 2024-06-18 | Iniziato | Cantor Fitzgerald | Overweight |
| 2022-07-20 | Iniziato | Goldman | Neutral |
| 2017-11-20 | Iniziato | Deutsche Bank | Hold |
Mostra tutto
Innoviva Inc Borsa (INVA) Ultime notizie
Innoviva (NASDAQ:INVA) Coverage Initiated at HC Wainwright - Defense World
What makes Innoviva Inc. stock price move sharplyTop Gaining Low Risk Assets - Newser
How Innoviva Inc. stock performs during market volatilityFree Stock Selection - Newser
Why Innoviva Inc. stock attracts strong analyst attentionChart Based Entries - Newser
HC Wainwright Initiates Innoviva at Buy With $40 Price Target - MarketScreener
This Cisco Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Cantor Fitzgerald Predicts Innoviva FY2026 Earnings - Defense World
Cantor Fitzgerald Begins Coverage on Innoviva (NASDAQ:INVA) - Defense World
New York State Teachers Retirement System Sells 3,448 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva, Inc. (NASDAQ:INVA) Shares Sold by Allspring Global Investments Holdings LLC - Defense World
Head to Head Analysis: Merck & Co., Inc. (NYSE:MRK) versus Innoviva (NASDAQ:INVA) - Defense World
(INVA) Long Term Investment Analysis - news.stocktradersdaily.com
Illinois Municipal Retirement Fund Sells 1,260 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva (NASDAQ:INVA) Ratio Stays Despite Growth Signs Nasdaq Composite - Kalkine Media
SG Americas Securities LLC Makes New $737,000 Investment in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Rhumbline Advisers Sells 9,188 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
FDA Grants Priority Review for Innoviva's (INVA) Zoliflodacin | - GuruFocus
FDA Grants Priority Review for Zoliflodacin New Drug Application for the Treatment of Uncomplicated Gonorrhea and Assigns Target PDUFA Date of December 15, 2025 - Kalkine Media
FDA reviews new gonorrhea antibiotic from Innoviva By Investing.com - Investing.com South Africa
FDA Reviews Innoviva's (INVA) Zoliflodacin for Gonorrhea Treatment - GuruFocus
Innoviva Says FDA Accepts New Drug Application for Zoliflodacin - MarketScreener
Innoviva Specialty's gonorrhea antibiotic to undergo FDA review (INVA) - Seeking Alpha
FDA reviews new gonorrhea antibiotic from Innoviva - Investing.com Australia
Innoviva Specialty Therapeutics Receives FDA New Drug Application Acceptance for Zoliflodacin, a First-in-Class Oral Antibiotic for Uncomplicated Gonorrhea in Adults - BioSpace
Innoviva (INVA) Awaits FDA Decision on New Gonorrhea Antibiotic | INVA Stock News - GuruFocus
Transcript : Innoviva, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 01 - MarketScreener
Innoviva: A Riddle Wrapped In A Mystery Inside An Enigma (NASDAQ:INVA) - Seeking Alpha
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Boosts Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World
INVA stock touches 52-week high at $21.35 amid robust gains - Investing.com Nigeria
Innoviva to Participate in Upcoming Investor Conferences - BioSpace
(INVA) Technical Pivots with Risk Controls - news.stocktradersdaily.com
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $546,000 Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Ameriprise Financial Inc. Has $2.50 Million Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva, Inc. (NASDAQ:INVA) Stock Holdings Lifted by Millennium Management LLC - Defense World
Innoviva, Inc. (INVA) Stock Analysis: 189.93% Potential Upside Sparks Investor Interest - DirectorsTalk Interviews
(INVA) Proactive Strategies - news.stocktradersdaily.com
Innoviva Elects Board Members and Approves Compensation - TipRanks
Bank of America Corp DE Decreases Holdings in Innoviva, Inc. (NASDAQ:INVA) - Defense World
ZEVTERA® (ceftobiprole), an Advanced-Generation Cephalosporin Antibiotic Now Commercially Available in the U.S. to Treat Three Types of Bacterial Infections - BioSpace
Innoviva (INVA) Launches New Antibiotic ZEVTERA for MRSA Treatme - GuruFocus
ZEVTERA(Ceftobiprole), An Advanced-Generation Cephalosporin Antibiotic Now Commercially Available In The U.S. To Treat Three Types Of Bacterial Infections - marketscreener.com
Basilea announces commercial availability of antibiotic Zevtera® (ceftobiprole) in the United States - GlobeNewswire
Cubist Systematic Strategies LLC Makes New $184,000 Investment in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva, Inc. (NASDAQ:INVA) Shares Bought by Northern Trust Corp - Defense World
Comerica Bank Sells 141,150 Shares of Innoviva, Inc. (NASDAQ:INVA) - Defense World
Armata Completes Crucial Bacteriophage Trial, Lands $4.65M Defense Contract Amid Strong Q1 Results - Stock Titan
(INVA) Investment Analysis - news.stocktradersdaily.com
Investor Network: Innoviva, Inc. to Host Earnings Call - ACCESS Newswire
Envestnet Asset Management Inc. Has $258,000 Stock Position in Innoviva, Inc. (NASDAQ:INVA) - Defense World
Innoviva, Inc. (INVA): Among Stocks with Insanely High PE Ratios Insiders Are Selling - Insider Monkey
Innoviva Inc Azioni (INVA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Innoviva Inc Azioni (INVA) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| DENNER ALEXANDER J | 10% Owner |
Mar 05 '25 |
Sale |
17.63 |
270,374 |
4,766,126 |
6,855,451 |
| DENNER ALEXANDER J | 10% Owner |
Mar 04 '25 |
Sale |
17.63 |
151,175 |
2,665,079 |
7,125,825 |
3.03%
2.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):